Recombinant Human Bone Morphogenetic Protein‐2 or Recombinant Human Platelet‐Derived Growth Factor BB in Extraction Site Preservation and Bone Augmentation

Craig M. Misch, Marc L. Nevins, Jason A. Boch · 2015

Tissue engineering promotes the interaction of native, or in some instances undifferentiated, osteoprogenitor cells with scaffolding matrices impregnated with genetically engineered growth factors such as bone morphogenetic proteins (BMPs) or platelet-derived growth factors (PDGFs). These two cytokines have been extensively studied. For example, intraoral clinical applications of recombinant human BMP-2 (rhBMP-2) have included extraction socket preservation and repair, sinus augmentation grafting, and alveolar ridge augmentation. This chapter gives case examples that demonstrate "off-label" clinical applications of rhPDGF-BB in guided bone regeneration (GBR) procedures. Using rhBMP-2 or rhPDGF-BB can reduce the invasiveness of alveolar bone grafting procedures needed for extraction site preservation or augmentation of healed and resorbed extraction sites by eliminating the need for autogenous bone grafts. After 4 months healing, the bone present is still primarily woven, so that use of hand osteotomes and/or undersizing of the osteotomy may be necessary to achieve adequate initial implant stability.

Cited by 2 works. doi:10.1002/9781119421405.ch7

Authors

References